Personality and Differential Treatment Response in Major Depression: A Randomized Controlled Trial Comparing Cognitive-Behavioural Therapy and Pharmacotherapy
Free accessResearch articleFirst published online June, 2008
Personality and Differential Treatment Response in Major Depression: A Randomized Controlled Trial Comparing Cognitive-Behavioural Therapy and Pharmacotherapy
Effective treatments for major depressive disorder exist, yet some patients fail to respond, or achieve only partial response. One approach to optimizing treatment success is to identify which patients are more likely to respond best to which treatments. The objective of this investigation was to determine if patient personality characteristics are predictive of response to either cognitive-behavioural therapy (CBT) or pharmacotherapy (PHT).
Method:
Depressed patients completed the Revised NEO Personality Inventory, which measures the higher-order domain and lower-order facet traits of the Five-Factor Model of Personality, and were randomized to receive either CBT or PHT.
Result:
Four personality traits—the higher-order domain neuroticism and 3 lower-order facet traits: trust, straightforwardness, and tendermindedness—were able to distinguish a differential response rate to CBT, compared with PHT.
Conclusion:
The assessment of patient dimensional personality traits can assist in the selection and optimization of treatment response for depressed patients.
Objectif:
Il existe des traitements efficaces du trouble dépressif majeur et pourtant, des patients ne réussissent pas à y répondre, ou n'y répondent que partiellement. Une approche en vue d'optimiser la réussite du traitement consiste à identifier quels patients sont plus susceptibles de mieux répondre à quels traitements. L'objectif de cette recherche était de déterminer si les caractéristiques de la personnalité des patients prédisent la réponse à soit la thérapie cognitivo-comportementale (TCC) soit la pharmacothérapie (PHT).
American Psychiatric Association. Practice guidelines for the treatment of patients with major depressive disorder (revision). Am J Psychiatry. 2000;157.
2.
Canadian Psychiatric Association, Canadian Network for Mood and Anxiety Treatments. Clinical guidelines for the treatment of depressive disorders. Can J Psychiatry. 2001;46:1S–92S.
3.
HollonSDThaseMEMarkowitzJC. Treatment and prevention of depression. Psychological Science in the Public Interest. 2002;3:39–77.
4.
JuddLLPaulusMPZellerP.The role of residual subthreshold depressive symptoms in early episode relapse in unipolar major depressive disorder. Arch Gen Psychiatry. 1999;56:764–765.
5.
ThaseMEHaightBRRichardNRemission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: A meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry. 2005;66:974–981.
6.
TrivediMHRushAJWisniewskiSREvaluation of outcomes with citalopram for depression using measurement-based care in STARD: Implications for clinical practice. Am J Psychiatry. 2006;163:28–40.
7.
ThaseME. How should efficacy be evaluated in randomized clinical trials of treatments for depression?J Clin Psychiatry. 1999;60:23–31.
8.
MattocksKMHorwitzRI. Placebos, active control groups, and the unpredictability paradox. Biol Psychiatry. 2000;47:693–698.
9.
KennedySHFarvoldenPCohenNLThe impact of personality on the pharmacological treatment of depression. In: RosenbluthMKennedySHBagbyRM, editors. Depression and personality: Conceptual and clinical challenges. Washington (DC): American Psychiatric Publishing; 2005. p 97–119.
10.
MulderRT. Personality pathology and treatment outcome in major depression: A review. Am J Psychiatry. 2002;159:359–371.
11.
CostaPTMcCraeRR. Revised NEO personality inventory (NEO-PI-R) and NEO five-factor inventory (NEO-FFI) professional manual. Odessa (FL): Psychological Assessment Resources; 1992.
12.
KoolSSchoeversRde MaatSEfficacy of pharmacotherapy in depressed patients with and without personality disorders: A systematic review and meta-analysis. J Affect Disord. 2005;88:269–278.
13.
Newton-HowesGTyrerPJohnsonT.Personality disorder and the outcome of depression: Meta-analysis of published studies. Br J Psychiatry. 2006;88:13–20.
14.
EysenckHJEysenckSB. Manual of the Eysenck personality inventory. London (GB): University of London; 1964.
15.
EysenckHJ. Manual of the Maudsley personality inventory. London (GB): University of London Press; 1959.
16.
CloningerCRSvrakicDMPrzybeckTR. A psychobiological model of temperament and character. Arch Gen Psychiatry. 1993;50:975–989.
17.
CloningerCR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry. 1987;44:573–588.
HarknessARMcNultyJL. The personality psychopathology five (PSY-5): Issues from the pages of a diagnostic manual instead of a dictionary. In: StrackSLorrM, editors. Differentiating normal and abnormal personality. New York (NY): Springer Publishing Co; 1994. p 291–315.
20.
BagbyRMJoffeRTParkerJDAMajor depression and the five-factor model of personality. J Personal Disord. 1995;9:224–234.
21.
DuLBakishDRavindranAVDoes fluoxetine influence major depression by modifying five-factor personality traits?J Affect Disord. 2002;71:235–241.
22.
PetersenTPapakostasGIBottonariKNEO-FFI factor scores as predictors of clinical response to fluoxetine in depressed outpatients. Psychiatry Res. 2002;109:9–16.
23.
ElkinISheaMTWatkinsJTNational institute of mental health treatment of depression collaborative research program: General effectiveness of treatments. Arch Gen Psychiatry. 1989;46:971–982.
24.
SotskySMGlassDRSheaMTPatient predictors of response to psychotherapy and pharmacotherapy: Findings in the NIMH treatment of depression collaborative research program. Am J Psychiatry. 1991;148:997–1008.
25.
WeissmanANBeckAT. Developmental validation of the dysfunctional attitude scale. Paper presented at the Annual Meeting of the Association of Advancement of Behavioral Therapy. Chicago (IL): 1978.
26.
BlattSJQuinlanDMPilkonisPAImpact of perfectionism and need for approval on the brief treatment of depression: The national institute of mental health treatment of depression collaborative research program revisited. J Consult Clin Psychol. 1995;63:125–132.
27.
BlattSJZuroffDCBondiCMWhen and how perfectionism impedes the brief treatment of depression: Further analyses of the national institute of mental health treatment of depression collaborative research program. J Consult Clin Psychol. 1998;66:423–428.
28.
RectorNABagbyRMSegalZVSelf-criticism and dependency in depressed patients treated with cognitive therapy or pharmacotherapy. Cognit Ther Res. 2000;24:571–584.
29.
BlattSJD'AffittiJPQuinlanDM. Experiences of depression in normal young adults. J Abnorm Psychol. 1976;85:383–389.
30.
McBrideCAtkinsonLQuiltyLCAttachment as moderator of treatment outcome in major depression: A randomized control trial of interpersonal psychotherapy versus cognitive behavior therapy. J Consult Clin Psychol. 2006;74:1041–1054.
31.
GriffinDWBartholomewK.The metaphysics of measurement: The case of adult attachment. In: BartholomewKPerlmanD, editors. Advances in personal relationships: Attachment processes in adulthood. London (GB): Jessica Kingsley; 1994. p 17–52.
32.
JoycePRMcKenzieJMCarterJDTemperament, character and personality disorders as predictors of response to interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry. 2007;190:503–508.
33.
FirstMBGibbonMSpitzerRLUser's guide for the structured clinical interview for DSM–IV Axis II personality disorders. Washington (DC): American Psychiatric Press; 1997.
34.
CohenJ.A power primer. Psych Bull. 1992;112:155–159.
35.
FirstMBSpitzerRLGibbonMStructured clinical interview for DSM–IV Axis I disorders—patient edition (version 2). New York (NY): Biometric Research Institute; 1995.
36.
HamiltonM.Development of a rating scale for primary depressive illness. J Clin Psychol. 1967;6:278–296.
37.
BagbyRMRyderAGSchullerDRThe Hamilton depressive rating scale: Have the gold standard become a lead weight?Am J Psychiatry. 2004;161:2163–2177.
38.
EbsteinRP. The molecular genetic architecture of human personality: Beyond self-report questionnaires. Mol Psychiatry. 2006;11:427–445.
39.
LevinsonDF. The genetics of depression: A review. Bio Psychiatry. 2006;60:84–92.
40.
McCraeRRAllikJ.The five-factor model across cultures. New York (NY): Kluwer-Plenum; 2002.
41.
McCraeRRTerraccianoA.Universal features of personality traits from the observer's perspective: Data from 50 cultures. J Pers Soc Psychol. 2005;88:547–561.
42.
BagbyRMBindseilKDSchullerDRRelationship between the five-factor model of personality and unipolar, bipolar, and schizophrenic patients. Psychiatry Res. 1997;70:83–94.
43.
BagbyRMLevitanRDKennedySHSelective alteration of personality in response to noradrenergic and serotonergic antidepressant medication in depressed sample: Evidence of non-specificity. Psychiatry Res. 1999;86:211–216.
44.
CostaPTBagbyRMHerbstJHPersonality self-reports are concurrently reliable and valid during acute depressive episodes. J Affect Disord. 2005;89:45–55.
45.
GreenbergerDPadeskyCA. Mind over mood: A cognitive therapy treatment manual for clients. New York (NY): Guilford Press; 1995.
46.
BeckATRushAJShawBFCognitive therapy of depression. New York (NY): Guilford Press; 1979.
47.
FrankEPrienRFJarrettRBConceptualization and rationale for consensus definitions of terms in major depressive disorder. Arch Gen Psychiatry. 1991;48:851–855.
48.
KnutsonBWolkowitzOMColeSWSelective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry. 1998;115:373–379.
49.
GaynesBNDavisLRushAJThe aims and design of the sequenced treatment alternative to relieve depression (STARD) study. Prim Psychiatry. 2005;12:36–41.
50.
VittenglJRClarkLADunnTWReducing relapse and recurrence in unipolar depression: A comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol. 2007;75:475–488.
51.
HorvathAOBediRP. The alliance in psychotherapy relationships that work: Therapist contributions and responsiveness to patients. NorcrossJC, editor. New York (NY): Oxford University Press; 2002.
52.
WaddingtonL.The therapy relationship in cognitive therapy: A review. Behav Cogn Psychother. 2002;30:179–192.
53.
TrullTJDurrettCA. Categorical and dimensional models of personality disorder. Annu Rev Clin Psychol. 2005;1:355–380.
54.
LivesleyWJJangKLVernonPA. Phenotypic and genetic structure of traits delineating personality disorder. Arch Gen Psychiatry. 1998;55:941–948.
55.
WidigerTA. Four out of five ain't bad. Arch Gen Psychiatry. 1998;55:865–866.
56.
McCraeRRCostaRT. Conceptions and correlates of openness to experience. In: HoganRJohnsonJABriggsSR, editors. Handbook of personality psychology. San Diego (CA): Academic Press; 1997. p 825–847.
57.
O'ConnorBP. A search for consensus on the dimensional structure of personality disorders. J Clin Psychol. 2005;61:323–345.
58.
LynamDRWidigerTA. Using the five-factor model to represent the DSM-IV personality disorders: An expert consensus approach. J Abnorm Psychol. 2001;110:401–412.
59.
MillerJDPilkonisPAMorseJO. Five-factor model prototypes for personality disorders: The utility of self-reports and observer ratings. Assessment. 2004;11:127–138.
60.
TrullTJWidigerTAUsedaJDA structured interview for the assessment of the five-factor model of personality. Psychol Assess. 1998;10:229–240.
61.
BagbyRMCostaPTWidigerTADSM-IV personality disorders and the five-factor model of personality: A multi-method examination of domain—and facet-level predictions. Eur J Pers. 2005;19:307–324.
62.
BagbyRMRectorNABindselKSelf-report ratings and informants' ratings of personalities of depressed outpatients. Am J Psychiatry. 1998;155:437–438.
63.
HeinzAJonesDWMazzantiCA relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Bio Psychiatry. 2000;47:643–649.
64.
LeschKBengelDHeilsAAssociation of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527–1531.
